National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection (RSV) in infants (summary, July 2022)
Practice Point: Duration of Antibiotic Therapy for Common Infections, Association of Medical Microbiology and Infectious Disease Canada
statements and practice points
Paediatrics & Child Health